EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Europe

Free tool simplifies cancer research

Every cell contains a vast number of proteins, each of which has a specific function, for example as a receptor for another molecule or an enzyme that catalyses che...
Continue Reading →
Europe

Roche concludes acquisition of Spark Therapeutics, Inc. to strengthen presence in gene therapy

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) ("Spark") today announced the completion of the acquisition following the receipt of ...
Continue Reading →
Europe

Clinerion and Pangaea partner to improve cancer patient lives

Clinerion, provider of the Patient Network Explorer platform which harnesses patient data from a global hospital network, and Pangaea, a machine learning company, pa...
Continue Reading →
Ensuring Appropriate and Reliable Data is Collected for Conclusive First-in-human/Phase I Trials
Volume 11 Issue 6

Ensuring Appropriate and Reliable Data is Collected for Conclusive First-in-human/Phase I Trials

The purpose of clinical trials is to find answers to a research question by generating data to prove or disprove a hypothesis. By their very nature, first-in-human (...
Continue Reading →
The Changing Face of Oncology Endpoint Monitoring
Volume 11 Issue 6

The Changing Face of Oncology Endpoint Monitoring

Oncology trials have always relied on tumour response to gauge the efficacy of the drugs they assess. The traditional primary endpoint for an oncology trial is tumou...
Continue Reading →
Clinically Important Endpoints to Measure Heart Failure
Volume 11 Issue 6

Clinically Important Endpoints to Measure Heart Failure

How treatments affect aspects of life that are most important to patients is a priority for the US Food and Drug Administration (FDA) as it seeks ways to facilitate ...
Continue Reading →
Volume 11 Issue 6

How to Prepare for an Inspection and Establish a Culture of Readiness

Preparing for a regulatory inspection can be daunting – but it doesn’t have to be. The stress of an inspection can be lessened by building inspection-readiness pract...
Continue Reading →
Addressing Regulatory Challenges in Clinical Trials of Cannabis-Related Drug Products
Volume 11 Issue 6

Addressing Regulatory Challenges in Clinical Trials of Cannabis-Related Drug Products

The past few years have witnessed a burgeoning global interest in the development of therapies related to cannabis (Cannabis sativa L.) and its components, including...
Continue Reading →
The MDR: The Clock is Ticking
Volume 11 Issue 6

The MDR: The Clock is Ticking

The European Union (EU) Medical Device Regulation (MDR) is the biggest challenge to the medical device industry in over 20 years. With the new regulations come more ...
Continue Reading →
Attracting Clinical Research to Malaysia with a Centralised Feasibility Platform
Volume 11 Issue 6

Attracting Clinical Research to Malaysia with a Centralised Feasibility Platform

A feasibility study is a crucial part of the clinical trial planning process. It enables sponsors and contract research organisations (CROs) to identify relevant cli...
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18